The use of cannabis, both for medical and recreational purposes, has experienced a notable surge in recent years. Indeed, cannabis remains the psychoactive drug most used worldwide, with an estimated 192 million users. At the same time, over 30 US states and almost all EU Member States have approved the use of cannabis or cannabis-based products for specific therapeutic applications, and some countries (e.g., ten US states, Canada, Uruguay) have legalized the commercial supply and sale of cannabis. This evolving landscape results in a worldwide expansion of the availability and use of cannabis and cannabis-based products, increasing concerns about their safety and potential risks, and thus urging a comprehensive compilation of data on the toxicity of cannabis.
These concerns span from immediate, acute effects to long-term, chronic consequences. Moreover, since cannabis is often used alongside other substances, it becomes crucial to understand potential toxicological interactions. Vulnerable populations, such as youth, pregnant women, and individuals with pre-existing health conditions, require special attention regarding cannabis-related risks.
While there is substantial research on cannabis effects, information is scattered and challenging to access. Known adverse effects include impaired cognitive function, mental health risks, addiction potential, and increased accident risk during activities like operating heavy machinery. Long-term cannabis use may also impact lung and cardiovascular health and cognitive development.
This Research Topic provides a dedicated platform for researchers, clinicians, and policymakers to share their latest findings, encompassing acute and chronic effects, substance interactions, dosage-related issues, and cannabis's impact on vulnerable populations.
The collection will provide a consolidated platform for researchers, clinicians, and policymakers to share their latest findings and insights, facilitating a deeper understanding of the health risks associated with cannabis medicinal and recreational consumption. This research will expectedly contribute to generating evidence-based guidelines for safer use.
For this Research Topic, we welcome submissions of original research, reviews, mini-reviews, methods, perspectives, community case studies, conceptual analysis, data reports, policy briefs, brief research reports, general commentaries, and opinions.
Keywords:
cannabis, adverse effects, drug interactions, drug regulation
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The use of cannabis, both for medical and recreational purposes, has experienced a notable surge in recent years. Indeed, cannabis remains the psychoactive drug most used worldwide, with an estimated 192 million users. At the same time, over 30 US states and almost all EU Member States have approved the use of cannabis or cannabis-based products for specific therapeutic applications, and some countries (e.g., ten US states, Canada, Uruguay) have legalized the commercial supply and sale of cannabis. This evolving landscape results in a worldwide expansion of the availability and use of cannabis and cannabis-based products, increasing concerns about their safety and potential risks, and thus urging a comprehensive compilation of data on the toxicity of cannabis.
These concerns span from immediate, acute effects to long-term, chronic consequences. Moreover, since cannabis is often used alongside other substances, it becomes crucial to understand potential toxicological interactions. Vulnerable populations, such as youth, pregnant women, and individuals with pre-existing health conditions, require special attention regarding cannabis-related risks.
While there is substantial research on cannabis effects, information is scattered and challenging to access. Known adverse effects include impaired cognitive function, mental health risks, addiction potential, and increased accident risk during activities like operating heavy machinery. Long-term cannabis use may also impact lung and cardiovascular health and cognitive development.
This Research Topic provides a dedicated platform for researchers, clinicians, and policymakers to share their latest findings, encompassing acute and chronic effects, substance interactions, dosage-related issues, and cannabis's impact on vulnerable populations.
The collection will provide a consolidated platform for researchers, clinicians, and policymakers to share their latest findings and insights, facilitating a deeper understanding of the health risks associated with cannabis medicinal and recreational consumption. This research will expectedly contribute to generating evidence-based guidelines for safer use.
For this Research Topic, we welcome submissions of original research, reviews, mini-reviews, methods, perspectives, community case studies, conceptual analysis, data reports, policy briefs, brief research reports, general commentaries, and opinions.
Keywords:
cannabis, adverse effects, drug interactions, drug regulation
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.